Macon Staples, who was recently diagnosed with B-Cell Acute Lymphoblastic Leukemia, was welcomed home with a parade in Pell ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

Sales of the firm's bispecific T-cell engager Blincyto increased more than 50 percent from the fourth quarter of 2023 to 2024.

The initiative kicked off yesterday with its first recipient: a brave young fan named Baker, who is battling an aggressive form of cancer.

Within days, a GoFundMe surpassed $50,000. To date, more than $70,000 has been donated to the fund. The Machias community ...

In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute ...